Okuno Mitsuru, Iwata Keisuke, Iwashita Takuji, Mukai Tsuyoshi, Shimojo Kota, Ohashi Yosuke, Iwasa Yuhei, Senju Akihiko, Iwata Shota, Tezuka Ryuichi, Ichikawa Hironao, Mita Naoki, Uemura Shinya, Yoshida Kensaku, Maruta Akinori, Tomita Eiichi, Yasuda Ichiro, Shimizu Masahito
Department of Gastroenterology, Gifu Municipal Hospital, Gifu, Japan; Department of Gastroenterology, Matsunami General Hospital, Gifu, Japan.
Department of Gastroenterology, Gifu Municipal Hospital, Gifu, Japan.
J Gastrointest Surg. 2025 May;29(5):102039. doi: 10.1016/j.gassur.2025.102039. Epub 2025 Mar 26.
Transpapillary preoperative biliary drainage (PBD) only for the future remnant liver (FRL) in hilar cholangiocarcinoma (HCCA) can be performed minimally invasively, with the expectation of swelling of the FRL. However, verification of the appropriate transpapillary unilateral PBD method for FRL is limited as the cases of liver resection are insufficient.
A total of 63 patients with resectable HCCA were evaluated. Of note, 12 unilateral across-the-papilla plastic stent (PS) placement cases (PS group), 14 unilateral intraductal PS (IS) placement cases (IS group), and 11 unilateral endoscopic nasobiliary drainage cases (ENBD group) met the inclusion criteria. Each group was compared in terms of the hospital stay duration for the endoscopic procedure, recurrent biliary obstruction (RBO), time to RBO (TRBO), overall survival (OS), and surgical outcomes.
No significant differences were observed in the patient characteristics between the groups. Hospital stay for the endoscopic procedure was significantly longer in the ENBD group (50 days [IQR, 33-163]) than in the PS group (14 days [IQR, 2-36]; P <.01) or IS group (21 days [IQR, 6-118]; P <.01). There were no significant differences in the RBO, TRBO, OS, surgical time, amount of intraoperative blood loss, or postsurgical adverse events (AEs) between the groups. In the multivariate analysis, there were no significantly related factors for RBO, TRBO, OS, and postsurgical AEs.
The PS, IS, and ENBD groups showed similar clinical outcomes in liver resection cases for HCCA, excluding the hospital stay duration for the endoscopic procedure. Considering the hospital stay duration, unilateral PS and IS placement can be considered acceptable for transpapillary PBD.
肝门部胆管癌(HCCA)中仅针对未来残余肝(FRL)进行经乳头术前胆管引流(PBD)可通过微创方式进行,预期FRL会肿大。然而,由于肝切除病例不足,对于FRL合适的经乳头单侧PBD方法的验证有限。
共评估了63例可切除的HCCA患者。值得注意的是,12例单侧经乳头放置塑料支架(PS)病例(PS组)、14例单侧导管内放置PS(IS)病例(IS组)和11例单侧内镜鼻胆管引流病例(ENBD组)符合纳入标准。比较了各组内镜手术的住院时间、复发性胆管梗阻(RBO)、RBO发生时间(TRBO)、总生存期(OS)和手术结果。
各组患者特征无显著差异。ENBD组内镜手术的住院时间(50天[四分位间距,33 - 163])显著长于PS组(14天[四分位间距,2 - 36];P <.01)或IS组(21天[四分位间距,6 - 118];P <.01)。各组之间在RBO、TRBO、OS、手术时间、术中失血量或术后不良事件(AE)方面无显著差异。在多因素分析中,RBO、TRBO、OS和术后AE均无显著相关因素。
在HCCA肝切除病例中,PS组、IS组和ENBD组显示出相似的临床结果,但不包括内镜手术的住院时间。考虑到住院时间,单侧PS和IS放置可被认为是经乳头PBD可接受的方法。